Merck KGaA (MRK) - Medical Equipment - Deals and Alliances Profile

Date: July 21, 2016
Pages: 122
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: ME17762A6D9EN
Leaflet:

Download PDF Leaflet

Merck KGaA (MRK) - Medical Equipment - Deals and Alliances Profile
Summary

Merck KGaA (Merck) is a pharmaceutical and chemical company, which operates its business in three markets namely, healthcare market, performance materials market and life sciences market. Its business operations include promoting prescription drugs of chemical and biological origin and over-the-counter products for preventive health care and the self-treatment of minor ailments (healthcare market); identifying, developing and manufacturing biotech and pharmaceutical drugs and general laboratory applications (life sciences market); and developing liquid crystal mixtures and cosmetic active ingredients (performance materials market). The company has operations in over 66 countries spread across Europe, North America, South America, Africa, Asia and Australia. It is a subsidiary of E. Merck KG and is headquartered in Darmstadt, Germany.

Merck KGaA (MRK) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
  • The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion/divestiture strategy
  • The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
  • Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
  • The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
  • Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
  • Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company.
Merck KGaA, Medical Equipment, Deals By Year, 2010 to YTD 2016
Merck KGaA, Medical Equipment Deals By Type, 2010 to YTD 2016
Merck KGaA, Medical Equipment, Deals By Region, 2010 to YTD 2016
Merck KGaA, Medical Equipment, Deals By Market, 2010 to YTD 2016
Merck KGaA, Medical Equipment, Deals Summary, 2010 to YTD 2016
Merck KGaA, Medical Equipment, Deal Details
Asset Purchase
Sigma-Aldrich Acquires Duolink Product Portfolio from Olink Bioscience
BioReliance To Acquire Rights To Big Blue Colonies and Cell Lines From Agilent Technologies
Partnerships
Sysmex Enters Into Licensing Agreement With Merck Millipore
MDxHealth Enters Into Licensing Agreement With Merck For MGMT Diagnostic Test
Sigma Aldrich Enters Into Licensing Agreement With HealthLinx
Proteome Sciences Enters Into License Agreement With Sigma-Aldrich
R-Biopharm Enters into Agreement with Merck
Emulate Expands Research Agreement with Merck
Merck and Pfizer Enters into Agreement with Dako
Sigma-Aldrich Enters into Distribution Agreement with LGC
Sigma-Aldrich and GenapSys to Co-Market Genius system
Merck Serono Enters into Co- Development Agreement with Illumina
Abcam Enters into Co-Marketing Agreement with Cell Marque for IVD IHC RabMAb Antibodies
Ventana Medical Systems Enters into Co-Development Agreement with Merck Serono for Companion Diagnostic Test
True Diagnostics Enters into Co-Marketing Agreement With Merck
Sigma-Aldrich Enters Into Distribution Agreement With Biomatrica For Biospecimen Storage Products
Firefly BioWorks Enters Into Distribution Agreement With EMD Millipore
Life Technologies Enters Into Agreement With Merck Serono To Develop And Commercialize Companion Diagnostics
Gyros And EMD Millipore Enter Into Agreement To Develop And Commercialize Immunoassay Kits
Luminex Extends Distribution Agreement With EMD Millipore
GE Healthcare Life Sciences Enters Into Distribution Agreement With Sigma-Aldrich
Sigma Life Science Enters Into Distribution Agreement With Olink Bioscience For Duolink Technology
EMD Millipore Enters Into Co-Development Agreement With Sistemic For Stem Cell Markers
Merck Serono Enters Into Co-Development Agreement With Auxogyn For Early Embryo Viability Assessment Test
Sage Labs Enters Into Agreement With Ekam Imaging To Develop Imaging Assays
SciFluor Life Sciences Enters Into Distribution Agreement With Sigma-Aldrich For PhenoFluor
Little Things Factory Enters Into Distribution Agreement With Sigma-Aldrich For Microreactors
Mendor Enters Into Distribution Agreement With Merck Serono
Fluxion Biosciences Enters Into Distribution Agreement With EMD Millipore
Diffinity Genomics Enters Into Distribution Agreement With Sigma-Aldrich
Sigma Life Science Signs An Agreement With Kraig Biocraft Labs
Merck Serono Enters Into Research Agreement With Philochem
Merck Extends Licensing Agreement with Progyny
Sigma-Aldrich Enters Into Licensing Agreement With Scripps Research Institute For Research Reagents
Cyprotex Enters Into Licensing Agreement With Sigma For Zinc Finger Nuclease Technology
Sigma Life Science Enters Into Licensing Agreement With King's College London
Millipore Enters into Licensing Agreement with Wayne State University
Debt Offering
Merck Raises USD916 Million in Private Placement of 0.75% Bonds Due 2019
Merck Raises USD801.4 Million in Private Placement of 0.23% Bonds Due 2017
Merck Raises USD629.7 Million in Private Placement of 1.375% Bonds Due 2022
Sigma-Aldrich Completes An Underwritten Public Offering Of Senior Notes Due 2020 For US$300 Million
Asset Transactions
Honeywell International Acquires Research Chemicals Business from Sigma-Aldrich
Omega Diagnostics Acquires Business And Certain Assets Of IVD Business From Allergopharma
Acquisition
Merck Acquires Sigma-Aldrich for USD17 Billion
Sigma-Aldrich Acquires Cell Marque
Proxy Labs Acquires MicroSafe Laboratories From Millipore
Sigma-Aldrich Completes Acquisition Of BioReliance For US$350 Million
EMD Millipore Completes Acquisition Of Amnis For US$103 Million
Merck Acquires heipha Dr. Muller And Related Assets From Biotest
Sigma-Aldrich Acquires Resource Technology
Merck Completes Acquisition Of Millipore
Merck KGaA - Key Competitors
Key Employees
Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Strategy And Business Planning
Jun 09, 2016: Consumer Health To Play A Pivotal Role In Merck's Africa Growth Strategy
Dec 10, 2015: Merck KGaA, Darmstadt, Germany, Confident for 2016
Oct 01, 2015: Merck Creates Greater Scope for Developing Ideas – Innovation Center o pened
Sep 15, 2015: Merck Streamlines Healthcare Management as Business Enters New Strategic Phase
Financial Announcements
Mar 08, 2016: Merck Finishes Record Year 2015 Stronger
Aug 06, 2015: Merck Reports Sales and Earnings Growth in Q2 2015
Corporate Communications
Apr 14, 2016: Merck Appoints Maya Martinez-Davis as Global Head of Oncology
Jan 27, 2016: Merck Announces New Biopharma Heads for North America and China
Nov 02, 2015: Merck KGaA, Darmstadt, Germany, Appoints Laszlo Radvanyi as Head of Global Immuno-Oncology Research
Jul 30, 2015: Merck Appoints Isabel De Paoli as new Head of Group Communications
Legal and Regulatory
Apr 14, 2016: Merck Responds to Legal Claims in the U.S.
Jan 15, 2016: Merck Announces Favorable English Court Ruling on Name Use
Product News
Feb 03, 2016: Merck Set To Launch New Version Of Fertility Pens
Other Significant Developments
Jul 19, 2016: MilliporeSigma Starts Construction on $115 Million Multi-faceted Life Science Campus in Burlington, Massachusetts
Jun 30, 2016: Merck Welcomes ZEISS and Hamilton Thorne as New Members of the Global Fertility Alliance
Jun 01, 2016: Merck’s Belen Garijo Receives Prestigious Career Award
May 19, 2016: Merck Increases Sales and Earnings in Q1 Following Sigma-Aldrich Acquisition
Apr 29, 2016: Merck Annual General Meeting 2016: CEO Handover After Ten Successful Years
Apr 26, 2016: Saviynt Selected by the Life Science Business of Merck KGaA, Darmstadt, Germany to Secure Its Next-Generation SAP and S/4HANA Platform
Mar 29, 2016: MilliporeSigma's CRISPR Epigenetic Activator Named to The Scientist's Top 10 Innovation List
Jun 11, 2015: Merck Serono Wins Two Red Dot Design Awards 2015 for High Quality Design of Fertility Pens
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Merck KGaA, Medical Equipment, Key Facts, 2015
Merck KGaA, Medical Equipment, Deals Summary, 2010 to YTD 2016
Merck KGaA, Medical Equipment, Deals By Year, 2010 to YTD 2016
Merck KGaA, Medical Equipment Deals By Type, 2010 to YTD 2016
Merck KGaA, Medical Equipment, Deals By Region, 2010 to YTD 2016
Merck KGaA, Deals By Market, 2010 to YTD 2016
Merck KGaA, Medical Equipment, Deals Summary, 2010 to YTD 2016
Sigma-Aldrich Acquires Duolink Product Portfolio from Olink Bioscience
BioReliance To Acquire Rights To Big Blue Colonies and Cell Lines From Agilent Technologies
Sysmex Enters Into Licensing Agreement With Merck Millipore
MDxHealth Enters Into Licensing Agreement With Merck For MGMT Diagnostic Test
Sigma Aldrich Enters Into Licensing Agreement With HealthLinx
Proteome Sciences Enters Into License Agreement With Sigma-Aldrich
R-Biopharm Enters into Agreement with Merck
Emulate Expands Research Agreement with Merck
Merck and Pfizer Enters into Agreement with Dako
Sigma-Aldrich Enters into Distribution Agreement with LGC
Sigma-Aldrich and GenapSys to Co-Market Genius system
Merck Serono Enters into Co- Development Agreement with Illumina
Abcam Enters into Co-Marketing Agreement with Cell Marque for IVD IHC RabMAb Antibodies
Ventana Medical Systems Enters into Co-Development Agreement with Merck Serono for Companion Diagnostic Test
True Diagnostics Enters into Co-Marketing Agreement With Merck
Sigma-Aldrich Enters Into Distribution Agreement With Biomatrica For Biospecimen Storage Products
Firefly BioWorks Enters Into Distribution Agreement With EMD Millipore
Life Technologies Enters Into Agreement With Merck Serono To Develop And Commercialize Companion Diagnostics
Gyros And EMD Millipore Enter Into Agreement To Develop And Commercialize Immunoassay Kits
Luminex Extends Distribution Agreement With EMD Millipore
GE Healthcare Life Sciences Enters Into Distribution Agreement With Sigma-Aldrich
Sigma Life Science Enters Into Distribution Agreement With Olink Bioscience For Duolink Technology
EMD Millipore Enters Into Co-Development Agreement With Sistemic For Stem Cell Markers
Merck Serono Enters Into Co-Development Agreement With Auxogyn For Early Embryo Viability Assessment Test
Sage Labs Enters Into Agreement With Ekam Imaging To Develop Imaging Assays
SciFluor Life Sciences Enters Into Distribution Agreement With Sigma-Aldrich For PhenoFluor
Little Things Factory Enters Into Distribution Agreement With Sigma-Aldrich For Microreactors
Mendor Enters Into Distribution Agreement With Merck Serono
Fluxion Biosciences Enters Into Distribution Agreement With EMD Millipore
Diffinity Genomics Enters Into Distribution Agreement With Sigma-Aldrich
Sigma Life Science Signs An Agreement With Kraig Biocraft Labs
Merck Serono Enters Into Research Agreement With Philochem
Merck Extends Licensing Agreement with Progyny
Sigma-Aldrich Enters Into Licensing Agreement With Scripps Research Institute For Research Reagents
Cyprotex Enters Into Licensing Agreement With Sigma For Zinc Finger Nuclease Technology
Sigma Life Science Enters Into Licensing Agreement With King's College London
Millipore Enters into Licensing Agreement with Wayne State University
Merck Raises USD916 Million in Private Placement of 0.75% Bonds Due 2019
Merck Raises USD801.4 Million in Private Placement of 0.23% Bonds Due 2017
Merck Raises USD629.7 Million in Private Placement of 1.375% Bonds Due 2022
Sigma-Aldrich Completes An Underwritten Public Offering Of Senior Notes Due 2020 For US$300 Million
Honeywell International Acquires Research Chemicals Business from Sigma-Aldrich
Omega Diagnostics Acquires Business And Certain Assets Of IVD Business From Allergopharma
Merck Acquires Sigma-Aldrich for USD17 Billion
Sigma-Aldrich Acquires Cell Marque
Proxy Labs Acquires MicroSafe Laboratories From Millipore
Sigma-Aldrich Completes Acquisition Of BioReliance For US$350 Million
EMD Millipore Completes Acquisition Of Amnis For US$103 Million
Merck Acquires heipha Dr. Muller And Related Assets From Biotest
Sigma-Aldrich Acquires Resource Technology
Merck Completes Acquisition Of Millipore
Merck KGaA, Key Competitors
Merck KGaA, Key Employees
Merck KGaA, Subsidiaries

LIST OF FIGURES

Merck KGaA, Medical Equipment, Deals by Type, 2010 to YTD 2016
Merck KGaA, Medical Equipment, Deals By Year, 2010 to YTD 2016
Merck KGaA, Medical Equipment, Deals By Region, 2010 to YTD 2016
Merck KGaA, Medical Equipment, Deals By Market, 2010 to YTD 2016
Merck KGaA, Medical Equipment, Deals By Year, 2010 to YTD 2016
Merck KGaA, Medical Equipment, Deals by Type, 2010 to YTD 2016
Merck KGaA, Medical Equipment, Deals By Region, 2010 to YTD 2016
Merck KGaA, Medical Equipment, Deals by Market, 2010 to YTD 2016
Skip to top


Ask Your Question

Merck KGaA (MRK) - Medical Equipment - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: